Heinz Feldmann, M.D.

Education:

Ph.D., 1988, University of Marburg, Germany

M.D., 1987, University of Marburg, Germany

Photo of Heinz Feldmann, M.D.

Heather Hickman, Ph.D.

Education:

Ph.D., University of Oklahoma

Photo of Heather Hickman, Ph.D.

Trial of Potential Universal Flu Vaccine Opens at NIH Clinical Center

A Phase 1 clinical trial of a novel influenza vaccine has begun inoculating healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The placebo-controlled trial will test the safety of a candidate vaccine, BPL-1357, and its ability to prompt immune responses. The vaccine candidate was developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID). The single-site trial can enroll up to 100 people aged 18 to 55 years and is led by NIAID investigator Matthew J. Memoli, M.D.

Contact

Submit a Media Request

Contact the NIAID News & Science Writing Branch.

301-402-1663
niaidnews@niaid.nih.gov
All Media Contacts

Richard Herbert, D.V.M.

Education:

D.V.M., 1993, Virginia-Maryland Regional College of Veterinary Medicine, College Park, MD

Intranasal Flu Vaccine with Nanoparticles Offers Robust Protection, Researchers Find

Media Type
Article
Publish or Event Date
Research Institution
Georgia State University
Short Title
Intranasal Flu Vaccine with Nanoparticles Offers Robust Protection, Researchers Find
Content Coordinator
Content Manager

To Better Protect Older Adults from the Flu, UConn, JAX, and Mount Sinai Team Up

Media Type
Article
Publish or Event Date
Research Institution
University of Connecticut School of Medicine
Short Title
To Better Protect Older Adults from the Flu, UConn, JAX, and Mount Sinai Team Up
Content Coordinator
Content Manager

Enesi Pharma Enters Agreement with National Institutes of Health to Evaluate ImplaVax®-enabled Flu Vaccines

Media Type
Article
Publish or Event Date
Research Institution
Enesi Pharma
Short Title
Enesi Pharma Enters Agreement with National Institutes of Health to Evaluate ImplaVax®-enabled Flu Vaccines
Content Coordinator
Content Manager

S. pneumoniae Sticks to Dying Lung Cells, Worsening Secondary Infection Following Flu

Media Type
Article
Publish or Event Date
Research Institution
University of Alabama at Birmingham
Short Title
S. pneumoniae Sticks to Dying Lung Cells, Worsening Secondary Infection Following Flu
Content Coordinator
Content Manager

Flu Fighter—Nanoparticle-Based Vaccine Effective in Preclinical Trials

Intranasal Influenza Vaccine Enhances Immune Response and Offers Broad Protection, Biomedical Sciences Researchers Find

Media Type
Article
Publish or Event Date
Research Institution
Georgia State University
Short Title
Intranasal Influenza Vaccine Enhances Immune Response and Offers Broad Protection, Biomedical Sciences Researchers Find
Content Coordinator
Content Manager